ClinConnect ClinConnect Logo
Search / Trial NCT06564142

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Launched by ALPINE IMMUNE SCIENCES INC, A SUBSIDIARY OF VERTEX · Aug 19, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Ig An Berger's Disease Glomerulonephritis Ig A Nephropathy Alpn 303 Baff B Ly S April

ClinConnect Summary

This clinical trial is studying a new medication called povetacicept for adults with Immunoglobulin A Nephropathy (IgAN), a condition that affects the kidneys and can lead to kidney damage. The main goal of the study is to see if povetacicept can help reduce protein in the urine and protect kidney function compared to a placebo, which is a substance with no active medicine. The trial is currently recruiting participants who are between the ages of 65 and 74 and have been diagnosed with IgAN within the last 10 years. To qualify, participants need to have a specific level of protein in their urine and a certain level of kidney function.

If you decide to participate, you'll be closely monitored throughout the study, and you'll receive either the study medication or a placebo. It's important to note that you should not have received certain treatments like immunosuppressive drugs or undergone specific procedures recently to be eligible. This trial could be an opportunity to help advance our understanding of IgAN and potentially find new ways to treat it.

Gender

ALL

Eligibility criteria

  • Key Inclusion Criteria:
  • Diagnosed IgAN, with biopsy confirmation
  • 24-hr proteinuria excretion ≥1.0 g/day or 24-hour uPCR ≥0.75 g/g
  • Estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73m\^2
  • Stable angiotensin converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARBs) as per protocol specification
  • Key Exclusion Criteria:
  • Have received any immunosuppressive treatment or procedures (including corticosteroids, oral immunosuppressive agents, B cell or plasma cell targeted therapies, complement targeted therapies, herbal medicines per protocol, and tonsillectomy) within a wash-out period per protocol
  • Rapidly progressive glomerulonephritis with eGFR reduction \>50% within 12 weeks of the start of screening
  • Other protocol defined Inclusion/Exclusion criteria may apply.

About Alpine Immune Sciences Inc, A Subsidiary Of Vertex

Alpine Immune Sciences Inc., a subsidiary of Vertex Pharmaceuticals, is a clinical-stage biotechnology company dedicated to advancing innovative immunotherapies for the treatment of cancer and autoimmune diseases. Leveraging its proprietary platform, Alpine focuses on the development of novel biologics that harness the immune system's potential to address unmet medical needs. With a commitment to scientific excellence and patient-centered research, Alpine collaborates with leading researchers and institutions to drive the discovery and development of transformative therapies that enhance patient outcomes.

Locations

Burlington, Vermont, United States

London, , United Kingdom

Jamaica, New York, United States

Hong Kong, , Hong Kong

Cork, , Ireland

Baltimore, Maryland, United States

Uppsala, , Sweden

Philadelphia, Pennsylvania, United States

New York, New York, United States

Woolloongabba, Queensland, Australia

Rochester, Minnesota, United States

Concord, , Australia

Ashkelon, , Israel

Goteborg, , Sweden

Paris, , France

Tel Hashomer, , Israel

Santiago De Compostela, , Spain

Vienna, , Austria

Seoul, , Korea, Republic Of

Valencia, , Spain

Taipei, , Taiwan

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Bergen, , Norway

Galway, , Ireland

Groningen, , Netherlands

Daegu, , Korea, Republic Of

Aalborg, , Denmark

Zagreb, , Croatia

Daegu, , Korea, Republic Of

Suwon, , Korea, Republic Of

Seoul, , Korea, Republic Of

Nijmegen, , Netherlands

Madrid, , Spain

Guangzhou, , China

Seoul, , Korea, Republic Of

Tartu, , Estonia

Feldkirch, , Austria

Miami, Florida, United States

Camperdown, , Australia

Ankara, , Turkey

Osaka, , Japan

Fukuoka, , Japan

Kobe, , Japan

Tokyo, , Japan

Tokyo, , Japan

Sevilla, , Spain

Bristol, , United Kingdom

Kyoto, , Japan

Vilnius, , Lithuania

Murdoch, Western Australia, Australia

Seoul, , Korea, Republic Of

Osaka, , Japan

Madrid, , Spain

Seongnam Si, , Korea, Republic Of

Anyang, , Korea, Republic Of

Pecs, , Hungary

Seoul, , Korea, Republic Of

Daejeon, , Korea, Republic Of

Cheonan, , Korea, Republic Of

Nanchang, , China

Kanazawa, , Japan

Bendigo, , Australia

Yantai, , China

Jinan, , China

Tupelo, Mississippi, United States

Chongqing, , China

Sao Paulo, , Brazil

Baton Rouge, Louisiana, United States

Heidelberg, , Australia

Newcastle, , Australia

Foshan, , China

Tianjin, , China

London, , United Kingdom

Shenyang, , China

Lauderdale Lakes, Florida, United States

Taipei, , Taiwan

Sheung Wan, , Hong Kong

San Francisco, California, United States

Fuzhou, , China

Albuquerque, New Mexico, United States

Ningbo, , China

Istanbul, , Turkey

Sapporo Shi, , Japan

Shijiazhuang, , China

Valmiera, , Latvia

New Taipei City, , Taiwan

Yinchuan, , China

Kitakyushu Shi, , Japan

Hangzhou, , China

Madrid, , Spain

Doral, Florida, United States

Murdoch, , Australia

Itabashi Ku, , Japan

Koshigaya, , Japan

Hefei, Anhui, China

Orlando, Florida, United States

Clayton, , Australia

Shanghai, , China

Guiyang, Guizhou, China

Taichung, , Taiwan

Seoul, Seoul Teukbyeolsi [Seoul], Korea, Republic Of

Seoul, Seoul Teukbyeolsi [Seoul], Korea, Republic Of

London, , United Kingdom

Beijing, , China

Changzhi, , China

Salt Lake City, Utah, United States

Guangzhou, , China

Hefei, , China

Lufkin, Texas, United States

Linz, , Austria

Arvada, Colorado, United States

Charlotte, North Carolina, United States

Seoul, Seoul Teukbyeolsi [Seoul], Korea, Republic Of

Houston, Texas, United States

Taiyuan, , China

Nantes, , France

Dallas, Texas, United States

Cangzhou, , China

Le Puy En Velay, , France

Denver, Colorado, United States

Genova, , Italy

Birtinya, , Australia

Seoul, , Korea, Republic Of

Glasgow, , United Kingdom

Dresden, , Germany

Hohhot, , China

Kita Ku, , Japan

Linköping, , Sweden

Zerifin, , Israel

Lincoln, Nebraska, United States

Orangeburg, South Carolina, United States

Huddinge, , Sweden

Guangzhou, , China

Fukuoka, , Japan

Coral Springs, Florida, United States

El Paso, Texas, United States

Huntsville, Alabama, United States

Madrid, , Spain

Pamplona, , Spain

Yongin Si, , Korea, Republic Of

Miami, Florida, United States

Garran, , Australia

Ningbo, , China

Miami, Florida, United States

Pasadena, Texas, United States

Glasgow, , United Kingdom

Lewisville, Texas, United States

East Providence, Rhode Island, United States

Changchun, , China

Shenzhen, , China

Juiz De Fora, , Brazil

Chongqing, , China

Guangzhou, Guangdong, China

Pompano Beach, Florida, United States

Los Angeles, California, United States

Hollywood, Florida, United States

Lawrenceville, Georgia, United States

Chubbuck, Idaho, United States

Idaho Falls, Idaho, United States

Meridian, Idaho, United States

Phoenix, Arizona, United States

Tucson, Arizona, United States

Albany, New York, United States

Katy, Texas, United States

Hollywood, Florida, United States

Melbourne, Florida, United States

Atlanta, Georgia, United States

Rockford, Illinois, United States

Edina, Minnesota, United States

Tokyo, , Japan

Metairie, Louisiana, United States

Shatin, , Hong Kong

Jinan, , China

Las Vegas, Nevada, United States

Manassas, Virginia, United States

Fremont, California, United States

Pembroke Pines, Florida, United States

Sweetwater, Florida, United States

Newnan, Georgia, United States

Naperville, Illinois, United States

Indianapolis, Indiana, United States

Hamilton, New Jersey, United States

Providence, Rhode Island, United States

Fairfax, Virginia, United States

Gosford, , Australia

Birmingham, , United Kingdom

Tallin, , Estonia

Orange, California, United States

Dallas, Texas, United States

Hamilton, , Canada

Louisville, Kentucky, United States

Newark, Delaware, United States

Miami, Florida, United States

Shelby, Michigan, United States

Knoxville, Tennessee, United States

Abilene, Texas, United States

Bellaire, Texas, United States

Ballarat, , Australia

Brisbane, , Australia

Reservoir, , Australia

Wels Grieskirchen, , Austria

Beijing, , China

Chengdu, , China

Dongguan, , China

Guilin, , China

Taian, , China

Wuxi, , China

Xuancheng, , China

Yichang, , China

Nový Jičín, , Czechia

Copenhagen, , Denmark

Bordeaux, , France

Creteil, , France

Marseille, , France

St Priest En Jarez, , France

Valenciennes, , France

Berlin, , Germany

Aichi, , Japan

Amagasaki, , Japan

Kahoku, , Japan

Kashihara, , Japan

Kasugai, , Japan

Kyoto Shi, , Japan

Miyazaki, , Japan

Tokyo, , Japan

Tokyo, , Japan

Tomigusuku, , Japan

Toyama Shi, , Japan

Urayasu Shi, , Japan

Cheonan, , Korea, Republic Of

Gangwon Do, , Korea, Republic Of

Gangwon Do, , Korea, Republic Of

Goyang Si, , Korea, Republic Of

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Riga, , Latvia

Kaunas, , Lithuania

Oslo, , Norway

Krakow, , Poland

Warszawa, , Poland

Danderyd, , Sweden

Kocaeli, , Turkey

Newcastle Upon Tyne, , United Kingdom

Stockton On Tees, , United Kingdom

Wirral (Liverpool), , United Kingdom

Houston, Texas, United States

Fuyang City, , China

Pavia, , Italy

Lleida, , Spain

Mishawaka, Indiana, United States

Jersey City, New Jersey, United States

Nantong City, , China

Yangzhou City, , China

Sendai Shi, , Japan

Tokyo, , Japan

Yancheng City, , China

Lin Yi City, , China

Zamosc, , Poland

Melbourne, , Australia

Belo Horizonte, , Brazil

Shaanxi, , China

Veracruz, , Mexico

Nove Mesto, , Czechia

Petah Tivka, , Israel

Taipei, , Taiwan

Zagreb, , Croatia

Kolding, , Denmark

Aachen, , Germany

Fresno, California, United States

Belo Horizonte, , Brazil

Brasilia, , Brazil

Rio De Janeiro, , Brazil

Sao Paolo, , Brazil

Luoyang, , China

Hillerod, , Denmark

Barcelona, , Spain

Cambridge, , United Kingdom

Goiania, , Brazil

Recife, , Brazil

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported